3 Results
Guidelines and Advice
Status: Current
ID: 24-2
Version: 2
ID: 24-2
Version: 2
Jan 2019
Drug
Jan 2022
Guidelines and Advice
Status: Current
ID: GL 2-33
ID: GL 2-33
Jun 2022